In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $19.08 in the prior trading day, Caredx Inc (NASDAQ: CDNA) closed at $18.23, down -4.45%. In other words, the price has decreased by -$4.45 from its previous closing price. On the day, 0.89 million shares were traded. CDNA stock price reached its highest trading level at $19.05 during the session, while it also had its lowest trading level at $18.13.
Ratios:
Our goal is to gain a better understanding of CDNA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.88 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 32.02. For the most recent quarter (mrq), Quick Ratio is recorded 3.72 and its Current Ratio is at 3.94. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.
BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 10 ’25 when Bickerstaff George sold 20,000 shares for $18.36 per share. The transaction valued at 367,102 led to the insider holds 103,027 shares of the business.
GEORGE W BICKERSTAFF bought 20,000 shares of CDNA for $367,102 on Mar 10 ’25. On Feb 04 ’25, another insider, Novack Jeffrey Adam, who serves as the Secretary and General Counsel of the company, sold 3,512 shares for $23.30 each. As a result, the insider received 81,829 and left with 104,677 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1057525888 and an Enterprise Value of 778127168. As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.92. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.03 while its Price-to-Book (P/B) ratio in mrq is 2.64. Its current Enterprise Value per Revenue stands at 2.331 whereas that against EBITDA is -19.671.
Stock Price History:
The Beta on a monthly basis for CDNA is 2.16, which has changed by 0.81368816 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $7.42. The 50-Day Moving Average of the stock is -15.26%, while the 200-Day Moving Average is calculated to be -20.82%.
Shares Statistics:
The stock has traded on average 840.50K shares per day over the past 3-months and 630430 shares per day over the last 10 days, according to various share statistics. A total of 54.77M shares are outstanding, with a floating share count of 51.94M. Insiders hold about 6.29% of the company’s shares, while institutions hold 100.45% stake in the company. Shares short for CDNA as of 1741910400 were 5741828 with a Short Ratio of 6.83, compared to 1739491200 on 4780214. Therefore, it implies a Short% of Shares Outstanding of 5741828 and a Short% of Float of 13.520001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
